Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monique Cosman Balhorn

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Protein and Peptide Letters|March 30, 2011
Protamines. EditorialMonique Cosman Balhorn, Rod Balhorn
Oncotarget|September 16, 2020
Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancersRod Balhorn, Monique Cosman Balhorn
Journal of Drug Targeting|June 27, 2020
The small molecule antibody mimic SH7139 targets a family of HLA-DRs expressed by B-cell lymphomas and other solid cancersRod Balhorn, Monique Cosman Balhorn, Karuppiah Balakrishnan, et al.
Veterinary Immunology and Immunopathology|June 26, 2010
A selective high affinity ligand (SHAL) designed to bind to an over-expressed human antigen on non-Hodgkin's lymphoma also binds to canine B-cell lymphomasRod L Balhorn, Katherine A Skorupski, Saphon Hok, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Protein and Peptide Letters|March 30, 2011
Protamines. EditorialMonique Cosman Balhorn, Rod Balhorn
Oncotarget|September 16, 2020
Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancersRod Balhorn, Monique Cosman Balhorn
Journal of Drug Targeting|June 27, 2020
The small molecule antibody mimic SH7139 targets a family of HLA-DRs expressed by B-cell lymphomas and other solid cancersRod Balhorn, Monique Cosman Balhorn, Karuppiah Balakrishnan, et al.
Veterinary Immunology and Immunopathology|June 26, 2010
A selective high affinity ligand (SHAL) designed to bind to an over-expressed human antigen on non-Hodgkin's lymphoma also binds to canine B-cell lymphomasRod L Balhorn, Katherine A Skorupski, Saphon Hok, et al.
Pageof 1